1

Increased Shots
on Goal

​Fund phase III approval studies that might otherwise be difficult to
finance internally

2

Expanded
Geographies

Overcome regional limitations, such as budget constraints
or conflicting priorities

3

Broadened
Pipeline

Finance phase III studies for external assets that are being acquired (M&A) or in-licensed

4

Broad Networks, Focused
Execution and Delivery

Obtain access to broad networks, focused execution and delivery:

  • Global clinical trial experience
  • Global regulatory expertise
  • ‘Hands on’ CRO management

Ready to talk?